EPS spoločnosti 180 Life Sciences
Aká je hodnota metriky EPS spoločnosti 180 Life Sciences?
Hodnota metriky EPS spoločnosti 180 Life Sciences Corp. je N/A
Aká je definícia metriky EPS?
Zisk na akciu (Earnings per share - EPS) je zisk spoločnosti na jednu akciu. Berie do úvahy riedenie akcií a počíta sa za posledných 12 mesiacov.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Čomu sa venuje spoločnosť 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.